HRT FINANCIAL LP

Position in QURE — uniQure N.V.

CIK 1475597 NEW YORK, NY

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,247,624

-$1,171,872 QoQ

Shares Held

135,641

-56.3% QoQ

Ownership

0.215%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#70

of 255 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. QURE ranks #34 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,247,624	135,641	-56.3%	Shares	Defined	2026-08-14
2025-12-31	$7,419,496	310,050	+991.0%	Shares	Defined	2026-02-12
2025-06-30	$396,174	28,420	+9.2%	Shares	Defined	2025-08-14
2024-09-30	$128,249	26,014	-42.2%	Shares	Defined	2024-11-12
2024-03-31	$234,182	45,035	-20.8%	Shares	Defined	2024-05-13
2023-12-31	$385,084	56,881	-73.1%	Shares	Defined	2024-02-09
2023-09-30	$1,420,144	211,646	+66.5%	Shares	Defined	2023-11-13
2022-12-31	$2,881,538	127,108	+41.7%	Shares	Defined	2023-02-10
2022-06-30	$1,671,709	89,684	+368.2%	Shares	Defined	2022-08-12
2021-12-31	$397,274	19,155	-57.0%	Shares	Defined	2022-02-14
2021-06-30	$1,371,585	44,532	+320.9%	Shares	Defined	2021-08-16
2020-06-30	$476,689	10,579	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.